European Journal of Vascular & Endovascular Surgery
Volume 31, Issue 3 , Pages 274-279, March 2006

Efficacy of Vancomycin, Teicoplanin and Fusidic Acid as Prophylactic Agents in Prevention of Vascular Graft Infection: An Experimental Study in Rat

  • A. Yasim

      Affiliations

    • Department of Cardiovascular Surgery, Faculty of Medicine, Kahramanmaras Sutcu Imam University, Turkey
    • Corresponding Author InformationCorresponding author. Alptekin Yasim, MD, Department of Cardiovascular Surgery, Faculty of Medicine, Kahramanmaras Sutcu Imam University, Kahramanmaraş, Turkey.
  • ,
  • M. Gul

      Affiliations

    • Department of Microbiology, Faculty of Medicine, Kahramanmaras Sutcu Imam University, Turkey
  • ,
  • E. Atahan

      Affiliations

    • Department of Cardiovascular Surgery, Faculty of Medicine, Kahramanmaras Sutcu Imam University, Turkey
  • ,
  • P. Ciragil

      Affiliations

    • Department of Microbiology, Faculty of Medicine, Kahramanmaras Sutcu Imam University, Turkey
  • ,
  • M. Aral

      Affiliations

    • Department of Microbiology, Faculty of Medicine, Kahramanmaras Sutcu Imam University, Turkey
  • ,
  • Y. Ergun

      Affiliations

    • Department of Pharmacology, Faculty of Medicine, Kahramanmaras Sutcu Imam University, Turkey

Accepted 23 September 2005. published online 16 December 2005.

Abstract 

Objectives

To compare the efficacy of a single prophylactic dose of intra-peritoneal vancomycin and teicoplanin with anti-biotic treated Dacron grafts (vancomycin, teicoplanin, 10 or 40% fusidic acid-soaked grafts) in preventing vascular graft infections in a rat model.

Design

Prospective, randomized, controlled animal study.

Materials and methods

The graft infections were established in the subcutaneous tissues of 80 female Sprague–Dawley rats by the implantation of Dacron prostheses followed by the topical inoculation with methicillin-resistant Staphylococcus aureus. The study groups were as follows: (1) uncontaminated control group, (2) untreated contaminated group, (3) contaminated group with intra-peritoneal vancomycin, (4) contaminated group with intra-peritoneal teicoplanin, (5) contaminated group received vancomycin-soaked Dacron graft, (6) contaminated group received teicoplanin-soaked Dacron graft, (7) contaminated group received 40% fusidic acid-soaked Dacron graft, and (8) contaminated group received 10% fusidic acid-soaked Dacron graft prophylaxis. The grafts were removed after 7 days and evaluated by a quantitative culture analysis.

Results

No infection was detected in controls. The untreated contaminated group had a high bacteria count (6.0×104CFU/cm2 Dacron graft). Groups that received intra-peritoneal vancomycin or teicoplanin had less bacterial growth (4.8×103 and 3.9×103CFU/cm2 Dacron graft, respectively). Similarly, the group that received 10% fusidic acid-soaked graft showed less bacterial growth (3.6×103CFU/cm2 Dacron graft). The groups with vancomycin-, teicoplanin- and 40% fusidic acid-soaked grafts showed no evidence of infection. Statistical analyses demonstrated that intra-peritoneal prophylactic antibiotic treatment was less effective in inhibiting bacterial growth than high concentration antimicrobial-soaking of grafts.

Conclusion

The use of vancomycin-, teicoplanin- and 40% fusidic acid-soaked grafts was effective in preventing primary prosthetic vascular graft infection.

Keywords: Vascular graft infection, Antibiotic prophylaxis, Rat model, Vancomycin, Teicoplanin, fusidic acid

 

PII: S1078-5884(05)00638-6

doi:10.1016/j.ejvs.2005.09.018

European Journal of Vascular & Endovascular Surgery
Volume 31, Issue 3 , Pages 274-279, March 2006